# Supernus Pharmaceuticals, Inc.: Form 8-K, filed Dec 20, 2024

- Company: [Supernus Pharmaceuticals, Inc.](/companies/supn.md) (CIK 1356576)
- Form: 8-K
- Filed: 2024-12-20
- Accepted by EDGAR: Dec 20, 2024, 16:10 ET
- Period: 2024-12-19
- Accession: 0001356576-24-000069
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1356576/000135657624000069/supn-20241219.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1356576/000135657624000069/

## Items reported

- Item 5.05: Item not in the standard list
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1356576/000135657624000069/supn-20241219.htm

Filed Dec 20, 2024.
Source: SEC EDGAR, the filing index for accession 0001356576-24-000069. Last ingested by Listed: Nov 4, 2026, 18:21 ET. No prices; not investment advice.